Warren Buffett’s State of the Market
Motley Fool Money
00:00
Psychedelics in Mental Health Treatment
This chapter explores the potential of psychedelic treatments, particularly LSD, in addressing mental health disorders like anxiety and depression. It discusses the innovative clinical research conducted by MindMed and the promising results from phase two studies, emphasizing the need for new therapeutic approaches in light of rising mental health issues. The conversation also highlights the complexities of clinical trials, regulatory challenges, and the significant implications of breakthrough therapy designations for psychedelic therapies.
Transcript
Play full episode
